Abstract:Despite extensive research, the exact mechanisms involved in colorectal cancer (CRC) etiology and pathogenesis remain unclear. This study aimed to examine the correlation between tumor-associated alternative splicing (AS) events and tumor immune infiltration (TII) in CRC. We analyzed transcriptome profiling and clinical CRC data from The Cancer Genome Atlas (TCGA) database and lists of AS-related and immune-related signatures from the SpliceSeq and Innate databases, respectively to develop and validate a risk model of differential AS events and subsequently a TII risk model. We then conducted a two-factor survival analysis to study the association between TII and AS risk and evaluated the associations between immune signatures and six types of immune cells based on the TIMER database. Subsequently, we studied the distribution of six types of TII cells in high- and low-risk groups for seven AS events and in total. We obtained the profiles of AS events/genes for 484 patients, which included 473 CRC tumor samples and 41 corresponding normal samples, and detected 22581 AS events in 8122 genes. Exon Skip (ES) (8446) and Mutually Exclusive Exons (ME) (74) exhibited the most and fewest AS events, respectively. We then classified the 433 patients with CRC into low-risk (n = 217) and high-risk (n = 216) groups based on the median risk score in different AS events. Compared with patients with low-risk scores (mortality = 11.8%), patients with high-risk scores were associated with poor overall survival (mortality = 27.6%). The risk score, cancer stage, and pathological stage (T, M, and N) were closely correlated with prognosis in patients with CRC ( P < 0.001). We identified 6479 differentially expressed genes from the transcriptome profiles of CRC and intersected 468 differential immune-related signatures. High-AS-risk and high-TII-risk predicted a poor prognosis in CRC. Different AS types were associated with different TII risk characteristics. Alternate Acceptor site (AA) and Alternate Promoter (AP) events directly affected the concentration of CD4T cells, and the level of CD8T cells was closely correlated with Alternate Terminator (AT) and Exon Skip (ES) events. Thus, the concentration of CD4T and CD8T cells in the CRC immune microenvironment was not specifically modulated by AS. However, B cell, dendritic cell, macrophage, and neutrophilic cell levels were strongly correlated with AS events. These results indicate adverse associations between AS event risk levels and immune cell infiltration density. Taken together, our findings show a clear association between tumor-associated alternative splicing and immune cell infiltration events and patient outcome and could form a basis for the identification of novel markers and therapeutic targets for CRC and other cancers in the future.

The Landscape of Alternative Splicing Reveals Novel Events Associated with Tumorigenesis and the Immune Microenvironment in Gastric Cancer

Systematic Profiling of Alternative Splicing in Helicobacter Pylori-Negative Gastric Cancer and Their Clinical Significance

Identification and Validation of Critical Alternative Splicing Events and Splicing Factors in Gastric Cancer Progression

Profiles of alternative splicing landscape in breast cancer and their clinical significance: an integrative analysis based on large-sequencing data

Identification of Novel Alternative Splicing Events Associated With Tumorigenesis, Protein Modification, and Immune Microenvironment in Early-Onset Gastric Cancer

Correlations Between the Characteristics of Alternative Splicing Events, Prognosis, and the Immune Microenvironment in Breast Cancer

Development and validation of an individual alternative splicing prognostic signature in gastric cancer

Integrative Bioinformatics Analysis of Prognostic Alternative Splicing Signatures in Gastric Cancer

Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data

Characterization of alternative splicing events and prognostic signatures in gastric cancer

Genome-wide identification of pan-cancer common and cancer-specific alternative splicing events in 9 types of cancer

Landscape of Alternative Splicing Events Related to Prognosis and Immune Infiltration in Glioma: A Data Analysis and Basic Verification

Systematic Analysis of Alternative Splicing Landscape in Pancreatic Adenocarcinoma Reveals Regulatory Network Associated with Tumorigenesis and Immune Response

Features of Alternative Splicing in Stomach Adenocarcinoma and Their Clinical Implication: a Research Based on Massive Sequencing Data

Analysis of Colorectal Cancer-Associated Alternative Splicing Based on Transcriptome.

Alternative Splicing Events and Subtype Analysis of Esophageal Cancer

Alternative Splicing in Glioblastoma and its Clinical Implication in Outcome Prediction

Survival-associated alternative splicing signatures in esophageal carcinoma

Survival-associated alternative splicing events interact with the immune microenvironment in stomach adenocarcinoma

Novel prognostic alternative splicing events in colorectal Cancer: Impact on immune infiltration and therapy response

Alternative Splicing Events in Tumor Immune Infiltration in Colorectal Cancer